Has Stephen Newman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,941 in general payments to Stephen Newman, MD across 43 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stephen Newman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stephen Newman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stephen Newman, MD

Pulmonary Disease · Denver, CONPI 1164497129

Payments from drug & device makers

$1,941in general payments, 2019–2025

Across 43 payments — averaging $45.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eko Health, Inc.$800
Avadel CNS Pharmaceuticals, LLC$200
Harmony Biosciences LLC$148
Jazz Pharmaceuticals Inc.$133
Boehringer Ingelheim$122
Insmed, Inc.$100
plus $439 from 18 others

What the payments were for

Consulting fees$20010%
Speaking & faculty fees$80041%
Food & beverage$77140%
Education$1709%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eko Health, Inc.	3	$800
Avadel CNS Pharmaceuticals, LLC	1	$200
Harmony Biosciences LLC	5	$148
Jazz Pharmaceuticals Inc.	4	$133
Boehringer Ingelheim	3	$122
Insmed, Inc.	1	$100
AstraZeneca	4	$58
Grifols USA, LLC	2	$36
Takeda Pharmaceuticals U.S.A., Inc.	2	$36
Actelion Pharmaceuticals US, Inc.	2	$35
QOL Medical, LLC	2	$32
Johnson & Johnson(2 entities)	2	$31
Beone Medicines USA, Inc.	1	$28
Daiichi Sankyo Inc.	1	$24
Merck	1	$21
Advanced Respiratory, Inc	1	$20
La Jolla Pharmaceutical Company	1	$18
Aimmune Therapeutics, Inc.	1	$17
Lilly USA, LLC	1	$16
Intercept Pharmaceuticals, Inc.	1	$15
Baxter Healthcare	1	$14
Mylan Specialty L.p.	1	$14
Novo Nordisk	1	$12
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LUMRYZ$200
OFEV$106

How this compares

$1,941 in reported general payments places this provider in the 60th percentile of 248 pulmonary disease providers in Colorado.

See all pulmonary disease providers in Colorado →

Medicare billing

Part B allowed, 2024

$13,450

Medicare patients

133

Services billed

231

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	16	$10,925

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Denver

Michael WechslerDenver$3.6M
Jennifer Taylor CousarDenver$1.4M
Evans Fernandez PerezDenver$1.3M
Ronald BalkissoonDenver$1.2M
Jeffrey SwigrisDenver$845K
Joshua SolomonDenver$705K
Marjorie GeorgeDenver$645K
Charles DaleyDenver$591K
Michael MohningDenver$588K
James CrapoDenver$357K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →